The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
The OGD Virtual Hiring Event
November 4, 2013
1:00 PM – 2:30 PM EST
Place: Virtual
To register, go to www.fda.gov/gdufahiring
Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), FDA is excited to announce our first Virtual Hiring Event. You will have the opportunity to meet the Director of the office along with other staff members and learn firsthand about the positions available within OGD. CDER’s Office of Generic Drugs is seeking talented, highly motivated and qualified individuals to help implement the Generic Drug User Fee Amendments of 2012 (GDUFA). This major FDA recruiting initiative is designed to speed access to safe and effective generic drugs to the public, and reduce costs to industry. Within OGD are health care providers, scientists, and many other professionals who strive to meet OGD’s mission, which is to promote and protect public health by overseeing the development and implementation of standards for the safety and effectiveness of generic drugs.
If you are having difficulties using Internet Explorer to register, please try a different browser such as Mozilla Firefox or Chrome. If you've never used Adobe Connect, get a quick overview: http://www.adobe.com/go/connectpro_overview .
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).